The Israeli Weekender
SEE OTHER BRANDS

Fresh news on arts and entertainment in Israel

The Israeli Weekender: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Israeli Weekender.

Press releases published on June 23, 2025

Aerial Imaging Market Size Expected to Reach $8.52 Billion by 2030

Aerial Imaging Market Size Expected to Reach $8.52 Billion by 2030

Global aerial imaging market was valued at $2.26 billion in 2020, and is projected to reach $8.52 billion by 2030, registering a CAGR of 14.2%. WILMINGTON, DE, UNITED STATES, June 23, 2025 /⁨EINPresswire.com⁩/ -- By application, the geospatial mapping …

Small Drones Market Size Expected to Reach $24.29 Billion by 2030

Small Drones Market Size Expected to Reach $24.29 Billion by 2030

Global small drones market was valued at $7.44 billion in 2020, and is projected to reach $24.29 billion by 2030, registering a CAGR of 13.16%. WILMINGTON, DE, UNITED STATES, June 23, 2025 /⁨EINPresswire.com⁩/ -- Increased operational efficiency and surge …

ZOOZ Power Explores Strategic Opportunities as Leading Defense Company Commences POC for Flywheel-Based Power Booster

ZOOZ Power Explores Strategic Opportunities as Leading Defense Company Commences POC for Flywheel-Based Power Booster

Board of Directors Announces Restructuring Plan Tel Aviv, Israel, June 23, 2025 (GLOBE NEWSWIRE) -- ZOOZ Power (Nasdaq and TASE: ZOOZ), a leading provider of flywheel-based power boosters and energy management systems for enabling ultra-fast EV charging …

LightSolver Selected as 2025 Technology Pioneer by the World Economic Forum

LightSolver Selected as 2025 Technology Pioneer by the World Economic Forum

TEL AVIV, Israel , June 23, 2025 (GLOBE NEWSWIRE) -- LightSolver, inventors of a new laser-based HPC computing paradigm, today announced that it has been named a 2025 Technology Pioneer by the World Economic Forum (WEF). With this recognition, LightSolver …

Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine

Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine

Final analysis of PEARL real world migraine prevention study presented at 11th Congress of the European Academy of Neurology (EAN 2025) Congress in Helsinki1,2 Fremanezumab demonstrated sustained effectiveness and a favourable safety and tolerability …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service